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PTP-1B = phosphatase 1B; ROS = reactive oxygen species; SERCA = sarco/endoplasmic reticulum calcium ATPase; SOD = superoxide dismutase.
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Abstract
Increases in reactive oxygen species (ROS) and tissue evidence of
oxidative injury are common in patients with inflammatory
processes or tissue injury. This has led to many clinical attempts to
scavenge ROS and reduce oxidative injury. However, we live in an
oxygen rich environment and ROS and their chemical reactions are
part of the basic chemical processes of normal metabolism.
Accordingly, organisms have evolved sophisticated mechanisms to
control these reactive molecules. Recently, it has become
increasingly evident that ROS also play a role in the regulation of
many intracellular signaling pathways that are important for normal
cell growth and inflammatory responses that are essential for host
defense. Thus, simply trying to scavenge ROS is likely not possible
and potentially harmful. The ‘normal’ level of ROS will also likely
vary in different tissues and even in different parts of cells. In this
paper, the terminology and basic chemistry of reactive species are
reviewed. Examples and mechanisms of tissue injury by ROS as
well as their positive role as signaling molecules are discussed.
Hopefully, a better understanding of the nature of ROS will lead to
better planned therapeutic attempts to manipulate the
concentrations of these important molecules. We need to regulate
ROS, not eradicate them.
Introduction
Production of reactive oxygen species (ROS) and oxidative
stress are associated with tissue injury and many pathological
processes, including septic shock [1,2]. This has prompted
clinical attempts to regulate oxygen radical production and
oxidative stress [3-7]. Signs of oxidative stress often have
been reduced, at least in blood, but by and large these
clinical trials have had little beneficial outcome, although a
reduction of mortality was observed in one trial [8] and a
reduction in multi-organ system failure in another [9]. An
underlying assumption has been that ROS randomly and
indiscriminately attack important chemical pathways and,
thereby, cause cell injury or death, but more recently it has
become evident that ROS can act as important signaling
molecules under physiological and pathophysiological
conditions [10-14]. Thus, to understand the potential benefits
and limitations of therapeutic approaches aimed at increasing
ROS scavenging, one must understand the ‘meaning’ of
oxidation and ROS. It will then become evident that although
ROS are potentially very toxic, they are also essential factors
in normal metabolism.
Oxygen is now the most prevalent element in the earth’s crust
[15]. It exists in air as a diatomic molecule, O2. Except for a
small number of anaerobic bacteria, all living organisms use O2
for energy production and it is thus essential for life as we know
it. Energy production from food material by organisms requires
‘oxidation’, which means the loss of electrons. In anaerobic
organisms, electrons are taken up by hydrogen, but in aerobic
organisms, the loss of electrons occurs much more efficiently
through the use of electron carriers such as nicotinamide
adenine dinucleotide (NAD+) and flavins, which are ‘reduced’
in the process by gaining electrons from target molecules and
are re-oxidized by donating electrons to O2 through oxidative
phosphorylation. The potential for O2 to oxidize other
molecules also makes it toxic. Oxidation is the basic process in
combustion; fires do not burn without O2. It is also the cause of
rust. Oxidation can inactivate important enzymes and
anaerobes that do not have anti-oxidant mechanisms do not
survive in an O2 environment. Thus, for organisms to have
evolved in an O2 world there has had to be evolution of potent
mechanisms to control oxidative processes.
Terminology
Before continuing with a discussion of potential beneficial
and harmful aspects of ROS, we need to review the terms
involved [15]. Oxidation is the gain of oxygen by a substance
or a loss of an electron. A useful reminder is ‘LEO’, which
stands for ‘lose electron oxidized’. Reduction is the loss of
oxygen by a substance, the gain of an electron or the gain of
hydrogen; a useful reminder is ‘GER’, which stands for ‘gain
electron reduced’. An oxidizing agent takes an electron or
hydrogen from another chemical or adds oxygen. A reducing
agent supplies electrons or hydrogen to another chemical, or
removes oxygen. An important chemical principle is that
because of their spin, electrons are most stable when they
are paired in their orbits. Unpaired electrons are attracted to
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magnetic fields, which makes them more reactive.
Substances that have unpaired electrons and are capable of
independent existence are called free radicals. By this
definition, atomic hydrogen is a free radical because it only has
one electron. O2 is a radical because it has two unpaired
electrons in its outer orbitals, and this gives O2 its reactivity.
However, the two unpaired electrons on O2 have parallel spins,
which means that O2 can only oxidize another molecule by
accepting a pair of electrons that have antiparallel spin so as to
fit into the two vacant spaces of O2. This tends to make O2
only accept one electron at a time and thus react sluggishly
with non-radicals. Thus O2 is the most stable state of oxygen.
Superoxide (O2
•–) has one more electron than O2. Since only
one electron is unpaired in O2
•–, it is simpler for it to accept an
electron and is thus more reactive than O2. However, O2
•– is
still not a very reactive radical; in the presence of H+ or HO2
• it
can reduce O2
•– to H2O2 or be oxidized to O2.
Another term that is often used is ‘reactive oxygen species’
(ROS). This term includes radicals as well as chemicals that
can take part in radical type reactions (i.e. gain or loose
electrons), but are not true radicals in that they do not have
unpaired electrons. Examples of non-radical ROS include
hydrogen peroxide (H2O2), hypochlorous acid (HOCl), ozone
(O3) and singlet oxygen (1∆gO2). An important product of the
two radicals O2
•– and NO is peroxynitrite (ONOO–); this
reaction occurs at a diffusion limited rate [16,17]. Although
not a radical itself, ONOO– can result in cytotoxic processes,
including lipid peroxidation, the formation of nitrotyrosine
residues that can inactivate enzymes, depletion of
glutathione, and DNA injury. Besides oxygen-based radicals,
there are also reactive nitrogen species such as nitric oxide
(NO) and nitrogen dioxide (NO2), sulfur based molecules
such as thinyl (RS) and perthinyl (RSS), as well as carbon
centered molecules such as trichloromethyl (CCl3
•), which is
a product of metabolism of carbon tetrachloride (CCl4) [15].
Sources of O2
•– and ROS
Under the conditions of normal metabolism the most important
source of O2
•– is the mitochondrial electron transport chain,
which leaks a few electrons directly onto O2 as part of normal
metabolism. It is estimated that 1% to 3% of O2 reduced in
mitochondria is in the form of O2
•– [18]. This comes from two
sites, complex 1 (NADH dehydrogenase) and complex III
(ubiquinone-cytochrome c reductase), with the latter being the
major source under normal conditions [11].
Several enzymes also contribute to O2
•– production. One of
the best characterized is xanthine oxidase, which is present in
the cytosol of many tissues but also can be found in
circulating blood and bound to glycosaminoglyan sites in the
arterial wall [19]. Normally the enzyme acts as a
dehydrogenase and transfers electrons to NAD+ rather than
O2, but in ischemia reperfusion [20,21] or in sepsis [21,22]
the active site of the enzyme is oxidized and the enzyme acts
as an oxidase and produces O2
•–.
In phagocytic cells the major source of O2
•– is a multi-
component oxidase called NAD(P)H oxidase [23,24]. In
response to membrane signals this complex produces a burst
of O2
•– that is important for killing invading microorganisms.
Genetic mutations in components of the complex result in
chronic granulomatous disease, which is characterized by
repeated infections. There are at least five components to the
complex. Two, p22phox (phox stands for phagocyte associated
oxidase) and gp91phox (subsequently called NOX2) are found
in membranes [25,26]. NOX2 is the component that
produces O2
•–. The complex is activated when the cytosolic
component p67phox is transported to the membrane complex
by the transporter molecule p47phox [27]. The attachment of
p67phox to the membrane complex results in a conformational
change in p22phox that exposes the active site on NOX2. The
small g-protein Rac also contributes to the activity of the
enzyme and transmits membrane signals to the complex.
Recently, a family of non-phagocytic NOXs with the same
basic components as the phagocytic type have been
identified in numerous types of cells, including vascular
smooth muscle, endothelial, skeletal muscle, fibroblast, and
mesangial cells [28-30]. The non-phagocytic form produces
much lower amounts of O2
•– compared to the phagocytic
form but is constitutively active.
O2
•– is also produced by a number of metabolically active
enzymes as part of their normal function or when there is
inadequate substrate. For example, cytochrome P450
enzymes can produce O2
•– as a side reaction when they
breakdown target molecules [15]. Nitric oxide synthases, the
family of enzymes that produce NO, produce O2
•– when the
substrates L-arginine or co-factor tetrahydropteridines are
insufficient [21,31,32].
O2
•– can also be produced by cyclooxygenase as part of
arachidonic acid metabolism. O2
•– even can be produced
through auto-oxidation of molecules such as gylceraldehyde,
FMNH2, FADH2, adrenalin, noradrenalin, dopamine and thiol
containing molecules such as cysteine in the presence of O2
[1,15]. Since we live in an oxygen rich environment, and ROS
are byproducts of normal metabolism, potent protective
mechanisms have evolved to allow life to continue. One of the
most fundamental antioxidant enzymes is superoxide
dismutase (SOD), which catalyzes the reaction of two O2
•–
and two H+ to H2O2 (reduced) and O2 (oxidized) [33]. There
are three forms to this enzyme: SOD1, a copper/zinc (Cu/Zn)
isoform present in the cytosol; SOD2, a manganese (Mn)
isoform present in mitochondria; and SOD3, a Cu/Zn isoform
present in the extracellular space. Knockout of SOD2 in mice
is lethal in the first week of life [34,35] whereas deficiencies
of SOD1 and SOD3 are not lethal but result in less tolerance
of neuronal injury [36] or hyperoxia, respectively [37]. H2O2
itself is not a radical but is a ROS and may actually account
for most of the O2
•– reactions. What makes H2O2 so
important is that it is more stable than O2
•– and can diffuse
across membranes. In the presence of iron in the ferrous formPage 3 of 8
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(Fe2+), H2O2 can be reduced to the highly reactive OH•
radical. It is thus important that H2O2 also be reduced in a
controlled manner and this is achieved by catalase or
glutathione peroxidase. Other antioxidants include cysteine,
glutathione itself, ascorbic acid (vitamin C) and α-tocopherol
(vitamin E), which can also scavenge peroxynitrite.
Production of injury by ROS
One of the major toxic effects of excessive ROS is damage to
cellular membranes by the process of lipid peroxidation.
Species such as OH•, HO2
•–, and OONO–, but not O2
•–, can
extract an H from methylene (-CH2-), which creates the
carbon radical -•CH-. This carbon radical then attacks other
-CH2- groups in lipid molecules, and creates a chain reaction
that alters the fluidity and shape of the membrane. This is the
same process that makes oil rancid. A consequence of the
change to the cell membrane is disruption of calcium
handling, which is essential for intracellular signaling. Lipid
peroxides can also damage DNA and proteins.
Attack of DNA by ROS results in DNA strand breaks. As with
lipids, O2
•– and H2O2 do not do this by themselves but do so
in the presence of hypochlorous acid (HOCl). It is also
possible that oxidative stress results in the release of bound
intracellular iron and copper ions that can then generate the
highly toxic OH• through what is known as the Fenton
reaction [15]. The potential for this to produce mutations and
to alter normal transcriptional and translational processes is
obvious. Besides these direct effects of oxidative injury, there
can be indirect injury because the nicks and breaks in DNA
strands can trigger activation of Poly(ADP) polymerase
(PARP), which alters gene expression, DNA replication and
may trigger apoptosis. It can also deplete NAD+, which leads
to cellular ATP depletion [38].
Proteins, too, can be targets of oxidative alterations. Protein
oxidation disrupts receptors, enzyme function and signal
transduction pathways. The amino acid tyrosine is particularly
prone to attack by ROS, especially reactive nitrogen species
such as OONO– [39]. The product of OONO– and tyrosine is
3-nitrotyrosine and antibodies against it are used as a
‘footprint’ of protein oxidation [40]. Oxidation of proteins also
can lead to products with carbonyl groups [41]. The amino
acids histidine, arginine, lysine and proline are especially
vulnerable. However, just because a protein is oxidized does
not mean that it has lost its function and the biological
significance of oxidation of a particular protein needs to be
confirmed by evidence of an alteration in function. An
example of a protein function altered by oxidation is the
inactivation of the intra-mitochondrial SOD, SOD2, by peroxy-
nitrite [42]. Because O2
•– scavenging is reduced, oxidative
processes are accelerated. Potentially important functional
sites for oxidation of proteins are the -SH groups because the
formation of -S-S- bonds between different protein strands or
parts of the same strand can result in conformational changes
in the protein that alter its function (see below).
ROS in sepsis
There is evidence from animal studies that an increase in
ROS in sepsis is of pathophysiological importance. Oxygen
radical scavengers reduce lung injury in animal models [43-
48] and improve hemodynamics [48,49]. An interesting and
potentially clinically important example of O2
•– induced injury
is the deactivation of catecholamines in inflammatory reactions
[50]. Catecholamines can act as antioxidants because of
their ability to interact with ROS, but this process also leads
to their deactivation and the formation of adrenochromes,
which are toxic themselves. Of interest, in the first
identification of SOD, one of the tests of the activity of the
enzyme was the prevention of oxidation of catecholamines
[33]. The potential clinical importance of the oxidation of
catecholamines was demonstrated by Salvemini and
coworkers [50] who showed that ROS decrease the activity
of catecholamines and oxygen radical scavengers restore
cardiovascular responsiveness to catecholamines in an
animal model of sepsis.
There is also evidence for a clinically significant role for ROS
in humans. Patients with sepsis who are able to achieve a
normal antioxidant potential in their plasma have better
survival [51] and treatment of septic patients with the
antioxidants glutathione and N-acetylcysteine decreases
measures of oxidative injury [4]. N-acetylcysteine reduces
the respiratory burst from neutrophils of septic patients [52]
and patients with lung injury randomized to antioxidant
therapy with N-acetylcysteine versus placebo had an
improvement in systemic oxygenation and a reduction in the
need for ventilatory support [5]. An improvement in hepatic
blood flow in septic patients has also been observed [6]. On
the other hand, no significant clinical advantage to the
administration of N-acetylcysteine was observed in two
studies [3,7]. An important limitation of N-acetylcysteine is
that it works by increasing the intracellular cysteine
concentration, which normally is high relative to the plasma
concentration [53]. Thus, potentially toxic plasma levels are
needed to reach the necessary intracellular levels. N-
acetylcysteine also has a low Km for the removal of O2
•–,
which is why it has to be present at high concentrations.
Augmenting oxygen radical scavenging activity in patients
with septic shock by combining N-acetylcysteine and
glutathione produced a trend towards less organ damage
[4] but results were not conclusive. To date there is no clear
evidence that antioxidant therapy alters outcome in septic
patients [54], although as noted in the introduction,
supplementation of feeds with vitamins was shown to reduce
mortality of a general group of severely ill patients [8] and
reduce multiorgan dysfunction in a group of critically ill
patients who were primarily trauma victims [9].
ROS and cell signalling
Perhaps the failure to find a clinical role for therapies aimed at
the reduction of ROS is that they are based on the limited
paradigm that ROS only cause injury. An alternative view is
Available online http://ccforum.com/content/10/1/208that although ROS are potentially highly toxic, redox reactions
are also part of the basic chemical processes of life [10,11].
Since organisms have had to develop efficient regulatory
mechanisms to keep the production of ROS under control,
these same mechanisms could be used to regulate other
intracellular processes [12-14,53,55]. A parallel might be
seen with that of Ca2+ handling. The intracellular Ca2+
concentration is kept at less than 1/10,000 of extracellular
Ca2+ so as to avoid the interaction of Ca2+ and phosphate
and bone formation. Because of the large transmembrane
gradient of Ca2+, the leak of small amounts of Ca2+ across
cell membranes through specialized channels can provide
one of the cell’s basic signalling mechanisms. Similarly,
regulation of extracellular and intracellular levels of O2
•– and
H2O2 could provide potential for signalling of extracelluar to
intracellular mechanisms. In this paradigm, ROS are not just
random destructive species but regulators of metabolic
processes and part of the chemistry of life [10,11]. Further-
more, evidence of oxidative injury may be the end result of the
inflammatory process rather than the major cause of injury, in
which case the use of antioxidants may be too late. Another
analogy might be helpful. Consider walking along a beach
and observing a rusted old ship lying on the shore. You
conclude that the reason why the ship was abandoned is
because it is so rusted (oxidized) until you walk past the ship
and notice a large hole in the hull. You then realize that the
ship was abandoned because of the hole and rusted when it
was no longer cared for. Signs of oxidative changes may
simply indicate that molecules or cells have been abandoned
by the organism and are not themselves the major cause of
the disease process.
Although there is a lot of evidence indicating that ROS and
the redox state have a signaling role in bacteria and plants,
there was less evidence in mammalian cells until recently. For
example, in bacteria the transcription factor OxyR is redox
sensitive [13]. There is now an increasing number of examples
in animals of ROS-based signaling, including protein tyrosine
phosphatase 1B (PTP-1B) [56], thioredoxin [57], SERCA2
[58] and Ras [59]. A well-characterized radical that has a
major role in normal physiological function is nitric oxide (NO•).
This radical has a central role in the regulation of vascular
tone, nerve function and immune regulation. Even the
potentially toxic by-product of NO• and O2
•–, OONO–, has
recently been shown to play a role in the regulation of vascular
tone [58]. Cohen and coworkers found that NO• induced
dilatation occurs by the production of low concentrations of
OONO–, which directly stimulates the sarco/endoplasmic
reticulum calcium (Ca2+) ATPase (SERCA) to decrease
intracellular Ca2+ and thereby produce vasodilatation. This
occurs by reversible S-glutathiolation of the thiol of a cysteine
molecule on SERCA. Thus, by removing O2
•– and preventing
the formation of OONO–, superoxide scavengers actually
blocked NO-induced vascular relaxation. However, high levels
of oxidative stress, including high concentrations of OONO–,
resulted in irreversible oxidation of key thiols and prevented
normal NO-induced relaxation. An important lesson may be
learnt from the NO system. Endothelial and neuronal cells that
use NO for signalling produce NO in small amounts, whereas
macrophages and neutrophils that use NO to attack invading
organisms produce large amounts. Similarly, the NAD(P)H
oxidase in phagocytic cells produces large quantities of O2
•–,
whereas the NAD(P)H oxidases in non-phagocytic cells
produce much smaller amounts of O2
•–, consistent with a
signalling role.
The role of ROS in the signaling of a number of growth factors
has also been well established. An excellent example is the role
of ROS in angiotensin signaling as established by Griendling
and co-workers [29,60-62]. They showed that exposure of
vascular smooth muscle to angiotensin II results in smooth
muscle growth that is dependent upon increased production of
O2
•– by NAD(P)H oxidase and its subsequent dismutation to
H2O2. H2O2 then activates downstream prosurvival pathways
and, in vivo, this results in vascular hypertrophy. Other growth
factors such as platelet derived growth factor have been
shown to have similar signaling mechanisms [63].
ROS also play a role in the intracellular signaling of tumor
necrosis factor-α [22,64-72] and this too seems to occur
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Figure 1
The change from thiols (-SH) to disulfide bonds (-S-S-) can produce a conformational change that may allow better protein-protein or protein-DNA
interactions. Adapted from Droge et al. [11].through O2
•– produced by NAD(P)H oxidase and likey
involves regulation of the transcriptional activity of NFκB.
Similarly, it has recently been shown that lipopolysaccharide
activation of Toll-like receptor 4 increases O2
•– production by
NAD(P)H oxidase and this too leads to NFκB activation [73].
Various mechanisms have been explored recently that can
explain how ROS can signal intracellular events. These
generally involve the oxidation of cysteine residues and
formation of -S-S- bonds [12,14,53,74,75] (Figs 1 to 3).
These bonds can be within a molecule and result in a
conformational change (Fig. 1) or between protein strands, in
which case they result in dimerization of proteins. The
creation of -S-S- bonds can also result in the release of an
inhibitory molecule (Fig. 2). Some reactions are irreversible
and result in protein instability or irreversible protein cross-
linking. However, an interesting reversible process is
oxidation of cysteinyl thiols by S-glutathiolation from thiol
disulfide exchange reactions involving oxidized glutathione or
from direct oxidation of protein cysteinyl thiols followed by
reaction with reduced glutathione [75] (Fig. 3). In the case of
PTP-1B, stabilization of an oxidized cysteine occurs through
the formation of a mixed disulfide with glutathione (Fig. 3).
The formation of the mixed disulfide prevents the irreversible
oxidation of the thiol to sulfinic or sulfonic acid and allows for
the reactivation of the enzyme by cellular thioreductase,
Available online http://ccforum.com/content/10/1/208
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Figure 2
Oxidation of thioredoxin (Trx) by hydrogen peroxide (H2O2) leads to a
change in shape of the molecule and the release of the transcriptional
factor ASK1. Trx is then reduced again by Trx reductase, which allows
it to again bind to ASK1 and inactivate this transcriptional factor.
Through this mechanism the redox state of the cell can regulate the
activity of the transcriptional factor ASK1.
Figure 3
Regulation of phosphatase by the redox state. Cysteine molecules have sulfur atoms (S) that are protonated and not reactive in most proteins.
However, on some molecules, such as phosphatases, S can form thiolates (S-) at normal pH and these can be reversibly oxidized. The top of the
figure shows the balance between phosphatase activity (which dephosphorylates molecules) and kinase activity (which phosphorylates and
activates molecules). Phosphatase activity is regulated by the redox state as shown in the cycle below the bracket. Oxidation to sulfenic acid (-S-
OH) is reversible. This can occur by glutathiolation (GSH) or by the formation of disulfides. However, excessive oxidation leads to sulfinic acid,
which cannot easily be converted back to reduced forms of sulfur.although recently it has become apparent that even sufinic
groups can be re-oxidized [76-78].
Implications
ROS are an essential part of many metabolic pathways; they
are part of the flame of basic energy producing processes.
Organisms have had to evolve elaborate mechanisms to live
with these reactive molecules and seem also to have evolved
to use the reactive nature of these molecules for intracellular
signal transduction. Thus, a key concept in dealing with ROS
must be to regulate but not eradicate, for turning off
production of ROS is tantamount to turning off the engine
that powers us. ROS also seem to have specific roles in
different cell types and thus therapeutic strategies for the
manipulation of ROS should take into account the source of
ROS, the targets of the ROS, specific cell types involved and
the specific location of ROS production in these cells, for one
needs to know that the potential therapeutic agent actually
can get to the site of excess ROS production. A list of things
to consider when examining the potential of a therapeutic
agent to deal with ROS is given in Table 1. In the manage-
ment of ROS we will need to be careful to not repeat the
mistake that was made with global inhibition of NO production.
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